Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

To perform literature and patent searches

— Life science entrepreneur, USA

To be aware of drugs likely to come off patent soon to help budget

— Hospital pharmacist, UK

To get Information about patents for active substance and indications

— Speciality pharmaceuticals, Israel

To have more information regarding the patents and generic products available

— Project manager, bioequivalence studies, Brazil

To find out patent expiration data for the Czech Republic

— Doctor, Czech Republic

Generated: May 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205677

« Back to Dashboard
NDA 205677 describes HETLIOZ, which is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the HETLIOZ profile page.

The generic ingredient in HETLIOZ is tasimelteon. One supplier is listed for this compound. Additional details are available on the tasimelteon profile page.

Summary for NDA: 205677

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Pharmacology for NDA: 205677

Mechanism of ActionMelatonin Receptor Agonists

Suppliers and Packaging for NDA: 205677

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HETLIOZ
tasimelteon
 CAPSULE;ORAL 205677 NDA Vanda Pharmaceuticals Inc. 43068-220 43068-220-01 30 CAPSULE in 1 BOTTLE (43068-220-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Jan 31, 2014TE:RLD:Yes
Patent:9,539,234Patent Expiration:Jan 25, 2033Product Flag?Substance Flag?Delist Request?
Regulatory Exclusivity Expiration:Jan 31, 2019
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Jan 31, 2021
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To find manufacturers of specific drugs, for import to Croatia and neighboring countries (Slovenia, Serbia, Bosnia, etc.)

— Commercial brokering, Croatia

For drug patent information

— Pharmaceutical business developer, USA

To obtain active pharmaceutical ingredient and pharmaceutical ingredient patents

— Marketing agency, UK

For information about patents on drugs of interest

— Information consultant, Mexico

To assess patent expiry dates as well as regulatory status of innovative drugs

— Pharmaceutical distributor, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot